Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

Drosha and Dicer are essential for hair follicle health and preventing DNA damage in skin cells.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

PCOS affects fertility and is linked to obesity and menstrual irregularities; lifestyle changes are recommended for treatment.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Women with PCOS have hormonal imbalances and increased central obesity, highlighting the need for early detection and management.

Some skin changes from pregnancy like hair loss, excessive hair growth, palm redness, and stretch marks may not go away after birth and could suggest a misdiagnosis or hidden condition.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Metformin improves acne, hair growth, and menstrual cycles in females with PCOS.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Estrogen helps promote hair growth in women with androgenetic alopecia.

A rare benign ovarian tumor caused virilization in a postmenopausal woman, treated successfully with surgery.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

Vitamin D Receptor is crucial for hair follicle shrinkage and cell death, affecting hair growth.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Postpartum hair loss usually stops within 4-6 months.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Minoxidil with Korean red ginseng improves hair density and thickness more than minoxidil alone.